idarubicin has been researched along with Cancer of Prostate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldayel, AS; Konoplev, S; Medeiros, LJ; Rich, A; Sun, J; Yin, CC | 1 |
| Li, Y; Liu, YN; Pan, YZ; Yu, H; Zhao, LJ; Zhao, XJ; Zhao, YY; Zhou, L | 1 |
| Ando, K; Kawada, H; Murayama, H; Nakamura, N; Ogawa, Y; Ohmachi, K; Suzuki, R; Tsuboi, K | 1 |
| Kidd, P; Quien, ET; Saidi, P; Sandhaus, L; Strair, R; Wallach, B | 1 |
| Bernhard, J; Castiglione, M; Gusset, H; Hanselmann, S; Hering, F; Maibach, R; Morant, R; Pestalozzi, D; Schmid, HP | 1 |
| Alken, P; Köhrmann, KU; Kreukler, C; Siegsmund, MJ; Stendler, A | 1 |
| Maibach, R; Schmid, HP; Semjonow, A | 1 |
| Fujita, H; Ishigatsubo, Y; Kanamori, H; Kihara, M; Maruta, A; Naitoh, A; Nakamura, S; Nozue, N; Ota, Y; Tomita, N | 1 |
| Bastholt, L; Bertelsen, K; Gadeberg, CC; Madsen, EL; Nielsen, ES; Rose, C | 1 |
2 review(s) available for idarubicin and Cancer of Prostate
| Article | Year |
|---|---|
Myelomastocytic leukemia with aberrant CD25 expression: case report and review of the literature.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Brain; Cerebral Hemorrhage; Cytarabine; Fatal Outcome; Humans; Hydroxamic Acids; Idarubicin; Interleukin-2 Receptor alpha Subunit; Leukemia, Myeloid, Acute; Leukemic Infiltration; Male; Mast Cells; Middle Aged; Neoplasms, Second Primary; Neoplastic Stem Cells; Opportunistic Infections; Prostatectomy; Prostatic Neoplasms; Vorinostat | 2014 |
Primary extramedullary leukemia of the prostate: case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnostic Errors; Doxorubicin; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prostatectomy; Prostatic Neoplasms; Radioisotope Teletherapy; Remission Induction; Urinary Retention; Vincristine | 1996 |
2 trial(s) available for idarubicin and Cancer of Prostate
| Article | Year |
|---|---|
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, Switzerland.
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Drug Resistance, Neoplasm; Humans; Idarubicin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms | 1997 |
Weekly oral idarubicin in advanced prostatic cancer. A phase II study.
Topics: Administration, Oral; Aged; Drug Administration Schedule; Drug Evaluation; Humans; Idarubicin; Male; Middle Aged; Neoplasm Staging; Pain; Prostatic Neoplasms; Remission Induction | 1992 |
5 other study(ies) available for idarubicin and Cancer of Prostate
| Article | Year |
|---|---|
[3,3-diindolylmethane enhances the inhibitory effect of idarubicin on the growth of human prostate cancer cells].
Topics: Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Indoles; Male; Matrix Metalloproteinase 9; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
[Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Dysuria; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Prostatic Neoplasms; Remission Induction; Sarcoma, Myeloid | 2008 |
Enhanced in vitro cytotoxicity of idarubicin compared to epirubicin and doxorubicin in rat prostate carcinoma cells.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Cell Division; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Idarubicin; KB Cells; Lethal Dose 50; Male; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 1997 |
Prostate-specific antigen doubling time: a potential surrogate end point in hormone-refractory prostate cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Humans; Idarubicin; Male; Multicenter Studies as Topic; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors | 1999 |
Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid.
Topics: Aged; Benzamidines; Dalteparin; Drug Administration Schedule; Gabexate; Guanidines; Humans; Idarubicin; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Male; Nephritis, Interstitial; Prostatic Neoplasms; Thrombophilia; Tretinoin | 2001 |